Oleic acid-based formulation enables drug delivery of bRo5 compounds through intestinal lymphatic absorption
- 24 March 2026
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 695, 126795
Abstract
No abstract availableKeywords
Funding Information
- AbbVie Deutschland
This publication has 41 references indexed in Scilit:
- Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical PropertiesPharmaceutical Research, 2020
- A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-SimJournal of Pharmacokinetics and Pharmacodynamics, 2017
- Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass MetabolismPharmaceutical Research, 2009
- Bile Increases Intestinal Lymphatic Drug Transport in the Fasted RatPharmaceutical Research, 2005
- Lipids, Lipophilic Drugs, and Oral Drug Delivery—Some Emerging ConceptsJournal of Pharmaceutical Sciences, 2000
- Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cellsAtherosclerosis, 1996
- Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzeneInternational Journal of Pharmaceutics, 1992
- Transport of lipophilic molecules by the intestinal lymphatic systemAdvanced Drug Delivery Reviews, 1991
- Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug moleculesInternational Journal of Pharmaceutics, 1986
- Effects of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDTInternational Journal of Pharmaceutics, 1986